GO:2001252 positive regulation of chromosome organization: Chromosome Organization Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:2001252 describes any process that activates or increases the frequency, rate or extent of chromosome organization, a broad biological process that includes chromosome condensation, sister chromatid cohesion, DNA repair, and maintenance of genome integrity.
• Key molecular drivers include chromatin remodelers, histone-modifying enzymes, and transcription elongation factors such as SPT5, which stabilizes RNA polymerase II and maintains the enhancer landscape.
• Dysregulation of positive regulation of chromosome organization is linked to cancer, autoimmune diseases, and meiotic recombination defects.
• HDAC inhibitors modulate epigenetic marks and can influence chromosome organization, making them promising cancer therapeutics.
• CRISPR-based knockout, point mutation, knock-in, and overexpression models are essential to dissect causal roles of genes within this GO term.
• High-throughput methods such as ATAC-seq, RNA-seq, and CRISPR library screening enable systematic discovery of regulators of chromosome organization.
Description
The Gene Ontology (GO) term GO:2001252, positive regulation of chromosome organization, encompasses any process that activates or increases the frequency, rate or extent of chromosome organization. This term is a critical node in the regulation of genome architecture, impacting processes from chromosome condensation and sister chromatid cohesion to DNA repair and maintenance of genome integrity. Researchers studying this term aim to understand how cells ensure proper chromosome dynamics during cell division, development, and stress responses. Disruption of these regulatory mechanisms is associated with a wide range of diseases, including cancer and autoimmune disorders. Recent studies have highlighted the role of transcription elongation factors, such as SPT5, in stabilizing RNA polymerase II and orchestrating transcription cycles that influence enhancer landscapes and chromosome organization. Additionally, epigenetic modulators like histone deacetylase (HDAC) inhibitors have been shown to affect chromosome organization and are being explored in cancer therapy. Understanding the positive regulation of chromosome organization is therefore fundamental for both basic biology and translational research.
positive regulation of chromosome organization At A Glance
| GO ID | GO:2001252 |
|---|---|
| GO term | positive regulation of chromosome organization |
| Ontology | biological_process |
| Synonym | positive regulation of chromosome organisation; positive regulation of chromosome organization and biogenesis; positive regulation of maintenance of genome integrity; positive regulation of nuclear genome maintenance |
| Major function | Activates or increases the frequency, rate or extent of chromosome organization |
| Related processes | Chromosome condensation, sister chromatid cohesion, DNA repair, maintenance of genome integrity |
| Key regulators | Chromatin remodelers, histone-modifying enzymes, transcription elongation factors (e.g., SPT5), and epigenetic modulators |
| Disease relevance | Cancer, autoimmune diseases, meiotic recombination defects |
What Is GO:2001252?
GO:2001252 is defined as any process that activates or increases the frequency, rate or extent of chromosome organization. It includes positive regulation of chromosome organisation, chromosome organization and biogenesis, maintenance of genome integrity, and nuclear genome maintenance. This term captures the upstream signals and molecular events that enhance the assembly, maintenance, and dynamic reorganization of chromosomes.
Why Is positive regulation of chromosome organization Important in Cell Biology?
Positive regulation of chromosome organization is essential for maintaining genomic stability and proper gene expression. Dysregulation of this process can lead to chromosomal instability, aneuploidy, and aberrant gene regulation, which are hallmarks of cancer and other diseases. Moreover, understanding how chromosome organization is positively regulated provides insights into fundamental cellular mechanisms such as transcription, DNA replication, and repair. This knowledge is also critical for developing therapeutic strategies that target epigenetic regulators and chromatin-associated factors.
• Maintains genome integrity by promoting proper chromosome condensation and segregation.
• Regulates gene expression through chromatin remodeling and enhancer landscape maintenance.
• Plays a role in DNA damage response and repair pathways.
• Dysregulation is linked to cancer, autoimmune diseases, and developmental disorders.
• Influences meiotic recombination and fertility.
• Provides targets for epigenetic therapies, such as HDAC inhibitors.
• Essential for stem cell function and differentiation.
• Can be studied using CRISPR-based functional genomics and high-throughput sequencing.
What Happens During positive regulation of chromosome organization?
Initiation of chromosome organization
In simple terms: The cell receives signals to start organizing its chromosomes.
Positive regulation of chromosome organization begins with upstream signals that activate chromatin-modifying enzymes and structural proteins. For example, phosphorylation of BRD4 by JNK switches its function to promote chromosome organization. Similarly, transcription elongation factor SPT5 stabilizes RNA polymerase II and maintains the enhancer landscape, which is crucial for chromosome organization.
Chromatin remodeling and histone modification
In simple terms: Proteins modify histones and DNA to make chromosomes more accessible or compact.
Chromatin remodelers and histone-modifying enzymes, such as HDACs, alter histone acetylation and methylation to regulate chromosome structure. These modifications can either promote or inhibit chromosome organization, depending on the context. For instance, HDAC inhibitors increase histone acetylation, leading to changes in chromosome organization and gene expression.
Chromosome condensation and cohesion
In simple terms: Chromosomes become tightly packed and sister chromatids are held together.
During mitosis and meiosis, positive regulation of chromosome organization ensures proper condensation and cohesion. Proteins like FIGNL1-FIRRM are essential for meiotic recombination and prevent DNA damage-independent RAD51 and DMC1 loading, which is critical for chromosome organization during meiosis.
Maintenance of genome integrity
In simple terms: The cell continuously repairs DNA and maintains chromosome structure.
Positive regulation of chromosome organization includes mechanisms that maintain genome integrity, such as DNA repair and checkpoint control. FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells, influencing chromosome organization and genome stability.
Key Genes Involved in GO:2001252 positive regulation of chromosome organization
The following genes and proteins are key players in the positive regulation of chromosome organization, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| SPT5 | Stabilizes RNA polymerase II and maintains enhancer landscape | Transcription elongation and chromosome organization |
| BRD4 | Chromatin reader and transcriptional regulator; phosphorylation by JNK switches functions | Chromosome organization and gene expression |
| HDACs | Histone deacetylases that remove acetyl groups from histones | Epigenetic modulation and cancer therapy |
| FOXP1 | Transcription factor regulating stem-like to effector transition | CAR T cell function and chromosome organization |
| KLF2 | Transcription factor regulating T cell quiescence and trafficking | CAR T cell function and chromosome organization |
| FIGNL1 | Meiotic recombination factor | Prevents DNA damage-independent RAD51 and DMC1 loading |
| FIRRM | Part of FIGNL1-FIRRM complex | Meiotic recombination and chromosome organization |
| FOXP3 | Regulatory T cell transcription factor | Autoimmune transcriptional circuit and T cell dysfunction |
| PRPF3 | Pre-mRNA processing factor; novel oncogene in hepatocellular carcinoma | Chromosome organization and cancer |
| Histones | Core chromatin proteins; extracellular histones as exosome membrane proteins | Cell stress and chromosome organization |
| RAD51 | DNA recombinase | Homologous recombination and chromosome organization |
| DMC1 | Meiosis-specific recombinase | Meiotic recombination |
| JNK | Stress-activated protein kinase | Phosphorylates BRD4 to switch functions |
| RNA polymerase II | Transcribes DNA to mRNA | Transcription cycles and enhancer landscape |
| PRPF3 | Splicing factor | Oncogene in hepatocellular carcinoma |
| HDAC inhibitors | Pharmacological agents | Cancer therapy and epigenetic modulation |
How Is positive regulation of chromosome organization Regulated?
Positive regulation of chromosome organization is controlled by a complex network of signaling pathways and epigenetic modifiers. For instance, JNK-mediated phosphorylation of BRD4 switches its function to promote chromosome organization. HDAC inhibitors modulate histone acetylation, thereby influencing chromosome structure and gene expression. Additionally, transcription elongation factors like SPT5 are regulated in a cell-cycle-dependent manner to maintain enhancer landscapes. These regulatory mechanisms ensure that chromosome organization is dynamically adjusted in response to cellular cues.
positive regulation of chromosome organization and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PRPF3 | Hepatocellular carcinoma | Knockout and overexpression in liver cancer cell lines |
| FOXP3 | Autoimmune diseases | Knockout and knock-in in T cells |
| FIGNL1 | Meiotic recombination defects | Knockout in mouse models |
| HDACs | Cancer | Knockout and point mutation in cancer cell lines |
| BRD4 | Cancer and inflammation | Point mutation (phosphorylation sites) in cell lines |
Cancer
Dysregulation of positive regulation of chromosome organization is frequently observed in cancer. For example, the novel oncogene PRPF3 is involved in hepatocellular carcinoma and is associated with chromosome organization. HDAC inhibitors, which modulate chromosome organization, are being developed as anticancer agents. Chromosomal instability resulting from defective chromosome organization can drive tumor progression.
Autoimmune diseases
An autoimmune transcriptional circuit drives FOXP3+ regulatory T cell dysfunction, which is linked to chromosome organization and gene regulation. Proper chromosome organization is essential for maintaining immune tolerance, and its disruption can lead to autoimmunity.
Meiotic recombination defects
FIGNL1-FIRRM is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading. Defects in this complex can lead to infertility and meiotic arrest, highlighting the importance of positive regulation of chromosome organization in germ cell development.
From positive regulation of chromosome organization-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X positively regulate chromosome organization? | CRISPR knockout cell lines |
| What is the effect of a specific point mutation in gene X on chromosome organization? | CRISPR point mutation knock-in |
| How does overexpression of gene X affect chromosome organization? | CRISPR overexpression (e.g., CRISPRa) models |
| Where does protein X localize during chromosome organization? | Tagged knock-in (e.g., GFP) and imaging |
| What are the downstream targets of gene X in chromosome organization? | RNA-seq and ATAC-seq after knockout/overexpression |
| Can we identify novel regulators of chromosome organization? | CRISPR library screening |
How to Study the positive regulation of chromosome organization Process
| Method | What It Measures | Typical Application |
|---|---|---|
| ATAC-seq | Chromatin accessibility | Identifying regulatory regions and chromosome organization |
| RNA-seq | Gene expression | Transcriptional changes upon perturbation |
| CRISPR library screening | Gene function at scale | Discovering regulators of chromosome organization |
| Proteomics | Protein interactions and abundance | Identifying complexes like FIGNL1-FIRRM |
| Hi-C | 3D chromosome conformation | Studying chromosome organization dynamics |
| ChIP-seq | Protein-DNA interactions | Mapping histone modifications and transcription factor binding |
| Live-cell imaging | Protein localization and dynamics | Visualizing chromosome organization in real time |
| Ribo-seq | Translation efficiency | Linking chromosome organization to protein synthesis |
ATAC-seq and RNA-seq
Assay for Transposase-Accessible Chromatin with sequencing (ATAC-seq) and RNA sequencing (RNA-seq) are powerful methods to study chromosome organization and gene expression. Integrative analysis based on ATAC-seq and RNA-seq revealed a novel oncogene PRPF3 in hepatocellular carcinoma, linking chromosome organization to cancer.
CRISPR library screening
CRISPR library screening allows systematic identification of genes that positively regulate chromosome organization. By knocking out genes across the genome, researchers can identify candidates that affect chromosome structure and function.
Proteomics and interactomics
Proteomic approaches can identify protein complexes involved in chromosome organization, such as the FIGNL1-FIRRM complex. These methods help elucidate the molecular mechanisms of positive regulation.
Imaging and chromosome conformation capture
Advanced imaging techniques and chromosome conformation capture (e.g., Hi-C) can visualize chromosome organization and its dynamic regulation in live cells.
How CRISPR Can Be Used to Study GO:2001252 positive regulation of chromosome organization
Knockout
CRISPR knockout is used to completely abolish gene function to test whether a candidate gene is necessary for positive regulation of chromosome organization. For example, knocking out PRPF3 in hepatocellular carcinoma cells can reveal its role in chromosome organization.
Point Mutation
CRISPR point mutation (base editing or prime editing) introduces specific nucleotide changes to study the effect of post-translational modifications or catalytic residues. For instance, mutating phosphorylation sites in BRD4 can elucidate how JNK-mediated phosphorylation switches its function in chromosome organization.
Knock-in
CRISPR knock-in allows the insertion of tags (e.g., GFP) or reporter genes to visualize protein localization and dynamics. Tagging SPT5 can help track its role in RNA polymerase II stabilization and enhancer landscape maintenance.
Overexpression
CRISPR activation (CRISPRa) or cDNA overexpression is used to increase gene expression and study gain-of-function effects on chromosome organization. Overexpressing HDACs or their mutants can reveal their impact on chromatin structure and cancer.
How EDITGENE Supports positive regulation of chromosome organization Research
Researchers studying positive regulation of chromosome organization-related genes often need to determine whether a candidate gene is causally involved in chromosome dynamics, genome stability, or disease progression. EDITGENE provides comprehensive CRISPR-based services to accelerate this research.
Contact EDITGENE today to design your custom CRISPR model for positive regulation of chromosome organization research.
Frequently Asked Questions About positive regulation of chromosome organization
What is GO:2001252 positive regulation of chromosome organization?
GO:2001252 is a Gene Ontology term for any process that activates or increases the frequency, rate or extent of chromosome organization, including chromosome condensation, cohesion, and genome integrity maintenance.
What genes are involved in positive regulation of chromosome organization?
Key genes include SPT5, BRD4, HDACs, FOXP1, KLF2, FIGNL1, FIRRM, FOXP3, PRPF3, and histones, among others.
How is positive regulation of chromosome organization studied?
Researchers use ATAC-seq, RNA-seq, CRISPR screening, proteomics, and imaging to study this process.
Why is positive regulation of chromosome organization important in cancer?
Dysregulation leads to chromosomal instability and cancer; genes like PRPF3 and HDACs are implicated.
What diseases are associated with defects in chromosome organization?
Cancer, autoimmune diseases, and meiotic recombination defects are linked to disrupted chromosome organization.
What are the synonyms for GO:2001252?
Synonyms include positive regulation of chromosome organisation, positive regulation of chromosome organization and biogenesis, positive regulation of maintenance of genome integrity, and positive regulation of nuclear genome maintenance.
How does SPT5 regulate chromosome organization?
SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape, which is crucial for chromosome organization.
Can CRISPR be used to study positive regulation of chromosome organization?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are widely used to dissect gene function in this process.
What is the role of HDAC inhibitors in chromosome organization?
HDAC inhibitors modulate histone acetylation, altering chromosome organization and gene expression, and are explored in cancer therapy.
How does FIGNL1-FIRRM complex function in meiosis?
FIGNL1-FIRRM is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading, ensuring proper chromosome organization.
Conclusion
Positive regulation of chromosome organization (GO:2001252) is a fundamental biological process that ensures genome stability and proper gene expression. Its dysregulation is implicated in cancer, autoimmune diseases, and meiotic defects. Continued research using advanced CRISPR models and high-throughput methods will further elucidate the molecular players and therapeutic opportunities.
References
- 1. Sumida TS et al.. 2024. An autoimmune transcriptional circuit drives FOXP3(+) regulatory T cell dysfunction.. Sci Transl Med 16(762):eadp1720 PMID: 39196959
- 2. Ramaiah MJ et al.. 2021. Epigenetic modulation and understanding of HDAC inhibitors in cancer therapy.. Life Sci 277:119504 PMID: 33872660
- 3. Hu S et al.. 2021. SPT5 stabilizes RNA polymerase II, orchestrates transcription cycles, and maintains the enhancer landscape.. Mol Cell 81(21):4425-4439.e6 PMID: 34534457
- 4. Singh B et al.. 2025. Extracellular Histones as Exosome Membrane Proteins Regulated by Cell Stress.. J Extracell Vesicles 14(2):e70042 PMID: 39976275
- 5. Bai Y et al.. 2024. Integrative analysis based on ATAC-seq and RNA-seq reveals a novel oncogene PRPF3 in hepatocellular carcinoma.. Clin Epigenetics 16(1):154 PMID: 39501301
- 6. Zhu Z et al.. 2024. FOXP1 and KLF2 reciprocally regulate checkpoints of stem-like to effector transition in CAR T cells.. Nat Immunol 25(1):117-128 PMID: 38012417
- 7. Zainu A et al.. 2024. FIGNL1-FIRRM is essential for meiotic recombination and prevents DNA damage-independent RAD51 and DMC1 loading.. Nat Commun 15(1):7015 PMID: 39147779
- 8. Devaiah BN et al.. 2024. Phosphorylation by JNK switches BRD4 functions.. Mol Cell 84(22):4282-4296.e7 PMID: 39454579
